Mechanism
How Umeclidinium works
Blocks muscarinic receptors in airway smooth muscle, especially M3 receptors, reducing acetylcholine-mediated bronchoconstriction and producing long-acting bronchodilation.
← Respiratory Pharmacology
LAMANBRC High Yield4/5 Importance
Umeclidinium Respiratory Pharmacology Guide
Class, mechanism, indications, adverse effects, kinetics, exam traps, and NBRC-style study pearls.
Umeclidinium is a long-acting muscarinic antagonist used for maintenance treatment of COPD. It blocks acetylcholine-mediated bronchoconstriction and provides long-duration bronchodilation. Its adverse effects are mainly anticholinergic, including dry mouth, constipation, urinary retention, and glaucoma-related caution. For NBRC-style questions, remember that LAMAs are maintenance bronchodilators and should not be selected for immediate relief of acute bronchospasm.
Clinical Pearl
What to remember
Like tiotropium, umeclidinium is maintenance therapy, not rescue therapy.
Kinetics
Onset, peak, and duration
1
Onset
Within 30 to 60 minutes
2
Peak
Several hours
3
Duration
Approximately 24 hours
Quick facts
- Subclass
- LAMA
- NBRC importance
- 4/5
- Difficulty
- 2/5
- Brands
- Incruse Ellipta
Common indications
- Maintenance treatment of COPD
- Long-term bronchodilator therapy
Adverse effects
- Dry mouth
- Cough
- Constipation
- Urinary retention
- Blurred vision
- Paradoxical bronchospasm
Contraindications
- Hypersensitivity to umeclidinium or formulation components
Cautions and safety issues
- Not for acute bronchospasm
- Use caution with narrow-angle glaucoma
- Use caution with urinary retention or prostatic hyperplasia
NBRC-style question
NBRC-style pharmacology review
A patient scenario involves stable copd patient needing maintenance bronchodilation. Which medication concept should the respiratory therapy student recognize?
High-yield answer
LAMA maintenance, not rescue
Interactive practice
Practice in PharmaGenius
Master this medication through adaptive review of class, mechanism, indications, adverse effects, exam traps, and clinical scenarios. Missed concepts can later be surfaced for targeted remediation.
ClassPractice
MechanismPractice
Clinical usePractice
Adverse effectsPractice
ScenarioPractice
Common Exam Traps
These are the answer choices, mechanisms, or medication classes most commonly confused with this medication on RT school and NBRC-style exams.
- Short-acting beta agonist
- Long-acting beta agonist
- Inhaled corticosteroid
- Used for acute rescue therapy
- Stimulates beta-2 receptors
High-Yield Clinical Scenarios
- Stable COPD patient needing maintenance bronchodilation
- COPD patient with persistent symptoms requiring once-daily LAMA
- Question distinguishing maintenance versus rescue bronchodilator therapy
Related study paths
Continue building pharmacology mastery
Use this medication page as a reference, then reinforce it with interactive practice and related PulmTools study resources.